Bruker Corp. (BRKR) CEO Purchases $48,639.60 in Stock
Bruker Corp. (NASDAQ:BRKR) CEO Frank H. Laukien acquired 2,124 shares of the stock in a transaction on Friday, November 25th. The shares were acquired at an average price of $22.90 per share, with a total value of $48,639.60. Following the transaction, the chief executive officer now directly owns 37,699,606 shares of the company’s stock, valued at $863,320,977.40. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
Bruker Corp. (NASDAQ:BRKR) opened at 22.68 on Thursday. The stock has a 50 day moving average of $21.80 and a 200-day moving average of $23.16. The stock has a market cap of $3.63 billion, a P/E ratio of 25.63 and a beta of 1.04. Bruker Corp. has a 12 month low of $19.58 and a 12 month high of $29.85.
Bruker Corp. (NASDAQ:BRKR) last posted its earnings results on Wednesday, November 2nd. The company reported $0.32 EPS for the quarter, beating the Zacks’ consensus estimate of $0.20 by $0.12. Bruker Corp. had a net margin of 9.02% and a return on equity of 26.05%. The company had revenue of $393.90 million for the quarter, compared to analysts’ expectations of $394.14 million. During the same quarter in the prior year, the company posted $0.19 earnings per share. Bruker Corp.’s revenue for the quarter was down .6% compared to the same quarter last year. On average, equities analysts forecast that Bruker Corp. will post $1.10 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, December 23rd. Shareholders of record on Monday, December 5th will be given a $0.04 dividend. The ex-dividend date of this dividend is Thursday, December 1st. This represents a $0.16 dividend on an annualized basis and a yield of 0.71%. Bruker Corp.’s payout ratio is currently 18.18%.
Several research firms have commented on BRKR. Leerink Swann began coverage on shares of Bruker Corp. in a research report on Thursday, November 10th. They set a “market perform” rating and a $21.00 price objective for the company. Zacks Investment Research upgraded shares of Bruker Corp. from a “hold” rating to a “buy” rating and set a $25.00 target price for the company in a report on Monday, November 7th. Cantor Fitzgerald restated a “buy” rating and issued a $28.00 target price on shares of Bruker Corp. in a report on Thursday, November 3rd. Barclays PLC lowered their target price on shares of Bruker Corp. from $32.00 to $30.00 and set an “overweight” rating for the company in a report on Wednesday, August 3rd. Finally, Morgan Stanley set a $23.00 target price on shares of Bruker Corp. and gave the stock a “hold” rating in a report on Wednesday, August 3rd. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. Bruker Corp. has a consensus rating of “Hold” and a consensus price target of $25.73.
Hedge funds and other institutional investors have recently bought and sold shares of the stock. GSA Capital Partners LLP boosted its position in Bruker Corp. by 86.0% in the second quarter. GSA Capital Partners LLP now owns 150,990 shares of the company’s stock worth $3,434,000 after buying an additional 69,804 shares during the last quarter. Old Mutual Global Investors UK Ltd. boosted its position in Bruker Corp. by 127.0% in the second quarter. Old Mutual Global Investors UK Ltd. now owns 310,063 shares of the company’s stock worth $7,050,000 after buying an additional 173,485 shares during the last quarter. Acadian Asset Management LLC boosted its position in Bruker Corp. by 78.2% in the second quarter. Acadian Asset Management LLC now owns 6,243,776 shares of the company’s stock worth $141,986,000 after buying an additional 2,740,421 shares during the last quarter. GW&K Investment Management LLC boosted its position in Bruker Corp. by 13.2% in the second quarter. GW&K Investment Management LLC now owns 104,408 shares of the company’s stock worth $2,374,000 after buying an additional 12,194 shares during the last quarter. Finally, Thompson Rubinstein Investment Management Inc. OR boosted its position in Bruker Corp. by 0.8% in the second quarter. Thompson Rubinstein Investment Management Inc. OR now owns 172,300 shares of the company’s stock worth $3,918,000 after buying an additional 1,370 shares during the last quarter. 67.74% of the stock is currently owned by institutional investors.
Bruker Corp. Company Profile
Bruker Corporation is a designer and manufacturer of scientific instruments, and analytical and diagnostic solutions. The Company’s operating segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment.
Receive News & Ratings for Bruker Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker Corp. and related companies with MarketBeat.com's FREE daily email newsletter.